John V. Herndon, Director at THERAGENICS CORP (TGX), bought 5,000 shares at $0.92 ($5K) on 2009-03-05, disclosed to the SEC on 2009-03-05.
Open-market purchase of $5k TGX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.